Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benign prostatic hyperplasia (the aging prostate).

J J Medina1, R O Parra, R G Moore

  • 1Division of Urology, St. Louis University School of Medicine, Missouri, USA.

The Medical Clinics of North America
|September 30, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dostarlimab and niraparib in primary advanced ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Coexistence of Surface Ferromagnetism and a Gapless Topological State in MnBi_{2}Te_{4}.

Physical review letters·2020
Same author

HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells.

Clinical and experimental immunology·2018
Same author

Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.

International journal of cancer·2017
Same author

Femtosecond electron-phonon lock-in by photoemission and x-ray free-electron laser.

Science (New York, N.Y.)·2017
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Benign prostatic hyperplasia (BPH) is common in aging men. Treatment for BPH varies from watchful waiting for mild symptoms to surgery for severe symptoms, with medical therapy for moderate cases.

Area of Science:

  • Urology
  • Gerontology

Background:

  • Benign prostatic hyperplasia (BPH) is a prevalent condition associated with aging.
  • BPH symptoms can range from mild discomfort to severe urinary retention and renal failure.

Purpose of the Study:

  • To outline the current treatment strategies for benign prostatic hyperplasia (BPH).
  • To emphasize the importance of individualized treatment plans for BPH management.

Main Methods:

  • This review synthesizes current clinical approaches to BPH management.
  • Treatment is stratified based on symptom severity: watchful waiting, medical therapy, and surgical intervention.

Main Results:

  • Mild BPH symptoms are managed with watchful waiting.
  • Moderate BPH symptoms are typically treated with medical therapy.

Related Experiment Videos

  • Severe BPH symptoms often require surgical intervention.

    • Conclusions:

    • Effective BPH management necessitates tailoring treatment to individual patient needs.
    • Medical therapy is the front-line approach for moderate BPH symptoms.
    • Less invasive treatment options for BPH are under development.